Diploma (LON:DPLM) Shares Cross Above 200 Day Moving Average of $3,291.54

Shares of Diploma PLC (LON:DPLM) passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 3,291.54 ($41.66) and traded as high as GBX 3,662 ($46.35). Diploma shares last traded at GBX 3,568 ($45.16), with a volume of 180,078 shares changing hands.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on DPLM shares. Berenberg Bank raised their target price on Diploma from GBX 3,800 ($48.10) to GBX 4,400 ($55.69) and gave the company a “buy” rating in a report on Thursday, March 28th. Shore Capital restated a “buy” rating on shares of Diploma in a report on Wednesday, March 27th.

Diploma Stock Down 0.6 %

The company has a quick ratio of 0.80, a current ratio of 2.06 and a debt-to-equity ratio of 44.05. The company has a market capitalization of £4.78 billion, a PE ratio of 3,964.44, a P/E/G ratio of 2.82 and a beta of 0.73. The stock has a 50-day moving average of GBX 3,458.28 and a 200 day moving average of GBX 3,293.77.

Diploma Increases Dividend

The firm also recently declared a dividend, which was paid on Friday, February 2nd. Investors of record on Thursday, January 18th were given a dividend of GBX 40 ($0.51) per share. This represents a dividend yield of 1.32%. This is an increase from Diploma’s previous dividend of $16.50. The ex-dividend date was Thursday, January 18th. Diploma’s dividend payout ratio (DPR) is presently 6,333.33%.

Diploma Company Profile

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.